Drexel Hamilton Reiterates Buy on Oracle (ORCL) Following 2Q Report

Wedbush Raises Price Target on Oracle (ORCL) Following 2Q Report

December 16, 2016 8:56 AM EST

Wedbush reiterated a Neutral rating on Oracle (NYSE: ORCL), and raised the price target to $42.00 (from $41.00), following the company's 2Q earnings report. revenues were roughly in line with consensus and EPS were at the top of the range. However, cloud bookings grew only 30% Y/Y (down from 39% last quarter),... More

Oracle (ORCL): North America At Low End Of Guidance But There Is A Silver Lining - Cowen

December 16, 2016 7:54 AM EST

Cowen analyst, Derrick Wood, reiterated his Outperform rating on shares of Oracle (NYSE: ORCL) but noted that the combo of some deal slippage in Cloud and efforts to deemphasize on-premise sales in its Apps biz led to ex-North American growth coming in at... More

Tech drags Wall Street lower; China tension weighs

December 16, 2016 7:32 AM EST

By Rodrigo Campos

NEW YORK (Reuters) - U.S. stocks fell on Friday, weighed by a more than 4 percent drop in Oracle shares, while recently battered stocks in the real estate and utilities sectors posted the largest gains.

Oracle dropped 4.3 percent to $39.10 after its adjusted revenue missed analysts' estimates. The stock was the biggest drag on the S&P and the tech sector.

Analysts said that investors were anxious and turned to defensive sectors in stocks as well as U.S.... More

Jefferies Reiterates Buy on Oracle (ORCL) Folowing 2Q Report

December 16, 2016 7:12 AM EST

Jefferies reiterated a Buy rating and $51.00 price target on Oracle (NYSE: ORCL) following the company's 2Q earnings report. Non-GAAP EPS of $0.61 and rev of $9.1B were about in line with consensus of $0.61 and $9.2B, although FX reduced revenue by about $90M and EPS by $0.01.... More

Options expected to have Increasing volume: YHOO ORCL ADBE

December 16, 2016 5:42 AM EST

Options expected to have Increasing volume: YHOO ORCL ADBE

... More

After-Hours Stock Movers 12/15: (JBL) (MRK) Higher; (AGIO) (FNSR) (ORCL) Lower (more...)

December 15, 2016 6:10 PM EST

Today's After-Hours

Agios Pharmaceuticals, Inc. (Nasdaq: AGIO) 19.6% LOWER; announced that it is no longer developing its second pyruvate kinase-R (PKR) activator, AG-519, and withdrew its investigational new drug (IND) application yesterday following a verbal notification of a clinical hold from the U.S. Food and Drug Administration (FDA). These decisions do not affect the Companys ongoing global Phase 2 study... More

Oracle (ORCL) Offers Q3 Guidance

December 15, 2016 5:21 PM EST

Oracle (NYSE: ORCL) sees Q3 adjusted EPS in constant currency of $0.61-$0.64 vs the consensus of $0.64. Revenue is seen up 3%-5% in constant currency.

... More

Oracle (ORCL) Tops Q2 EPS by 1c

December 15, 2016 4:00 PM EST

Oracle (NYSE: ORCL) reported Q2 EPS of $0.61, $0.01 better than the analyst estimate of $0.60. Revenue for the quarter came in at $9.07 billion versus the consensus estimate of $9.12 billion.

"For four consecutive quarters our Cloud SaaS & PaaS revenue growth rate has increased," said Oracle CEO, Safra Catz. "As we get bigger in the cloud, we grow faster in the cloud. Our non-GAAP constant currency SaaS and PaaS growth rate... More

Oracle (ORCL) December 40.50 straddle priced for movement of 3.4% into Q2

December 15, 2016 2:44 PM EST

Oracle (NYSE: ORCL) December 40.50 straddle priced for movement of 3.4% into Q2

... More

Oracle (ORCL) December volatility at elevated at 85 into Q2

December 15, 2016 12:59 PM EST

Oracle (NYSE: ORCL) December call option implied volatility is at 87, December is at 37; January is at 23; compared to its 52-week range of 14 to 34 into the expected release Q2 results today.

... More